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Genomic structural variants (SVs) are abundant in humans, differing from other variation 
classes in extent, origin, and functional impact. Despite progress in SV characterization, 
the nucleotide resolution architecture of most SVs remains unknown. We constructed a 
map  of  unbalanced  SVs  (i.e.,  copy  number  variants)  based  on  whole  genome  DNA 
sequencing data from 185 human genomes, integrating evidence from complementary SV 
discovery approaches with extensive experimental validations. Our map encompassed 
22,025 deletions and 6,000 additional SVs, including insertions and tandem duplications. 
Most SVs (53%) were mapped to nucleotide resolution, which facilitated analyzing their 
origin and functional impact. We examined numerous whole and partial gene deletions 
with a genotyping approach and observed a depletion of gene disruptions amongst high 
frequency deletions. Furthermore, we observed differences in the size spectra of SVs 
originating from distinct formation mechanisms, and constructed a map of SV hotspots 
formed by common mechanisms. Our analytical framework and SV map serves as a 










and  Crohn’s  disease6,7.  Furthermore,  locus‐specific  studies  suggest  that  diverse 






origin  and  impact,  requires  knowledge  of  precise  SV  sequences.  Advances  in 
sequencing  technology  have  enabled  applying  sequence‐based  approaches  for 
mapping SVs at fine‐scale14,15,16,17,18,19,20,21. These approaches include: (i) paired‐end 
mapping  (or  read  pair  ‘RP’  analysis)  based  on  sequencing  and  analysis  of 
abnormally  mapping  pairs  of  clone  ends14,22,23,24  or  high‐throughput  sequencing 
fragments15,17,18; (ii) read‐depth (‘RD’) analysis, which detects SVs by analyzing the 
read  depth‐of‐coverage16,21,25,26,27;  (iii) split‐read  (‘SR’)  analysis,  which  evaluates 
gapped sequence alignments for SV detection28,29; and (iv) sequence assembly (‘AS’), 
which  enables  the  fine‐scale  discovery  of  SVs,  including  novel  (non‐reference) 
sequence insertions30,31,32. Sequence‐based SV discovery approaches have thus far 
been  applied  to  a  limited  (<20)  number  of  genomes,  leaving  the  fine‐scale 
architecture of most common SVs unknown. 
Sequence  data  generated  by  the  1000  Genomes  Project  (1000GP)  provide  an 
unprecedented  opportunity  to  generate  a  comprehensive  SV  map.  The  1000GP 
recently generated 4.1 Terabases of raw sequence in pilot projects targeting whole 
human genomes33 (Supplementary Table 1). These studies comprise a population‐
scale  project,  termed  ‘low‐coverage  project’,  in  which  179  unrelated  individuals 
were sequenced with an average coverage of 3.6X – including 59 Yoruba individuals 
from Nigeria (YRI), 60 individuals of European ancestry from Utah (CEU), 30 of Han 
ancestry  from  Beijing  (CHB),  and  30  of  Japanese  ancestry  from  Tokyo  (JPT;  the 
latter two were jointly analyzed as JPT+CHB). In addition, a high‐coverage project, 
termed  the  ‘trio  project’,  was  carried  out,  with  individuals  of  a  CEU  and  a  YRI 
parent‐offspring trio sequenced to 42X coverage on average.   
We  report  here  the  results  of  analyses  undertaken  by  the  Structural  Variation 
Analysis Group of the 1000GP. The group’s objectives were to discover, assemble, 
genotype, and validate SVs of 50 bp and larger in size, and to assess and compare 
















to  the  reference  genome,  or  to  a  set  of  individuals  (i.e.  population  reference; 
Supplementary  Table  2).  We  initially  identified  SVs  as  deletions,  tandem 
duplications,  novel  sequence  insertions,  and  mobile  element  insertions  (MEIs) 









reported  elsewhere33.  Many  SVs  exhibited  support  from  distinct  SV  discovery 
methods, as exemplified by a common deletion, previously associated with body‐
mass  index35  (BMI),  that  we  identified  with  RP,  RD,  and  SR  methods  (Fig.  1C). 
Nonetheless,  we  observed  notable  differences  between  methods  (Fig.  2ABC)  in 
terms of genomic regions ascertained (Supplementary Fig. 1), accessible SV size‐
range (Fig. 2A), and breakpoint precision (Fig. 2C, Supplementary Fig. 2).  
To  estimate  callset  specificity,  we  carried  out  extensive  validations  (Methods), 
including  PCRs  for  over  3,000  candidate  loci,  and  microarray  data  analyses  for 
50,000  candidate  loci  (Supplementary  Tables  3,  4;  Supplementary  Fig.  3).  We 
combined PCR and array‐based analysis results to estimate false discovery rates 
(FDRs), and found that eight callsets (three deletion, four insertion, and one tandem 
duplication  callset)  met  the  pre‐specified  specificity  threshold33  (FDR≤10%), 
whereas the other callsets yielded lower specificity (FDRs of 13%‐89%).  
We further assessed the sensitivity of deletion discovery methods by collating data 






the  low‐coverage  data,  the  individual  method  with  the  greatest  accuracy 
(FDR=3.7%) was the second most sensitive based on our gold standard (Fig. 2B), 
















bp  overlap  criterion.  When  instead  applying  a  stringent  50%  reciprocal  overlap 
criterion for sensitivity assessment (which required SV sizes inferred on different 
experimental  platforms  to  be  in  close  agreement)  our  sensitivity  estimates 
decreased  by  12%  and  18%,  respectively,  in  trio  and  low‐coverage  sequence 
(Supplementary  Table  8).  We  further  examined  an  alternative  approach  that 
involved  the  pairwise  integration  of  deletion  discovery  methods,  and  tested  its 
ability to discover SVs without relying on the inclusion of lower specificity calls 
following  experimental  validation  (“algorithm‐centric  set”;  Fig.  1B).  While  this 
alternative approach resulted in an increased number (by ~13%) of high‐specificity 




















duplications,  initially  discovered  by  RD,  RP,  and  PD  methods  (Methods, 
Supplementary  Table  2).  Altogether,  we  mapped  ~15,000  SVs  at  nucleotide 
resolution, 48% of which were novel. Few deletion loci (4.4%) displayed different 
SV  breakpoints  in  different  samples,  which  is  explainable  by  rare  TIGRA  mis‐
assemblies,  or  alternatively,  by  recurrently  formed,  multi‐allelic  SVs 
(Supplementary Text). TIGRA further enabled us to validate an additional 7,359 SVs 
discovered with RP or RD features by identifying the SVs’ breakpoints (Methods), 
and  to  evaluate  the  mapping  precision  of  SV  discovery  methods  (Fig.  2C, 
Supplementary Figure 2).  
We further assessed the putative functional impact of SVs in our set by relating 
them  to  genomic  annotation.  Seventeen  hundred  SVs  affected  coding  sequences, 
resulting in full gene overlaps or exon disruptions (Table 2), many of which led to 
out‐of‐frame exons (Supplementary Table 9). We related gene disruptions to gene 
functions,  and  observed  significant  enrichments  for  several  functional  categories 
including  cell  defense  and  sensory  perception  (Supplementary  Table 10).  High 
levels  of  structural  variation,  including  copy‐number  variation,  were  previously 








association  studies  in  the  form  of  a  reference  genotype  set.  In  this  regard,  the 
Genome  STRiP36  genotyping  method  was  developed,  a  method  combining 
information from RD, RP, SR and haplotype features of population‐scale sequence 
data  for  genotyping  (Methods,  Supplementary  Text).  Using  this  approach  we 
generated  genotypes  for  13,826  autosomal  deletions  in  156  individuals.  The 
genotypes  displayed  99.1%  concordance  with  CGH  array1  based  genotypes 
(available for 1,970 of the deletions), suggesting high genotyping accuracy.  
Fig. 3 presents allele frequency analyses based on these genotypes. As expected, 
common  polymorphisms  (minor  allele  frequency  (MAF)  >5%)  were  generally 
shared across populations, while rare alleles were frequently observed in only one 
population  (Figs.  3ABC).  We  observed  several  candidates  for  monomorphic 
deletions (i.e., genomic segments putatively deleted in all individuals), explainable   7 





(P=1.1x10‐11;  KS  test),  consistent  with  purifying  selection  keeping  most  gene 
deletions at low frequency. Nonetheless, several coding sequence deletions were 
observed  with  high  allele  frequency  (>80%).  Most  of  these  occurred  in  regions 





differentiation  and  particular  categories  of  gene  overlap,  i.e.,  intronic  vs.  exonic 
(Supplementary Text). 
By  comparing  deletion  genotypes  with  genotypes  of  nearby  SNPs,  we  found, 
consistent with earlier studies1,13,40, that deletions in genomic regions accessible to 
short  read  sequencing  display  extensive  linkage  disequilibrium  (LD)  with  SNPs. 
81%  of  common  deletions  had  one  or  more  SNPs  with  which  they  are  strongly 










Nucleotide  resolution  breakpoint  information  enables  inference  of  SV  formation 





associated  with  DNA  repair  by  non‐homologous  end‐joining  (NHEJ)  or  with 
microhomology‐mediated  break‐induced  replication  (MMBIR);  the  shrinking  or 






using  the  BreakSeq  classification  approach43.  This  analysis  showed  that  of  the 
11,254  nucleotide‐resolution  SVs  discovered  as  deletions  relative  to  a  human 






state  of  8.4%  remained  undetermined  (Supplementary  Text).  Our  breakpoint 
analysis revealed that 70.8% of the deletions and 89.6% of the insertions exhibited 








We  subsequently  applied  BreakSeq43  to  infer  formation  mechanisms  for  all  SVs 






MEIs  at  300  bp,  corresponding  to  Alu  elements,  and  at  6  kb,  corresponding  to 
L1/LINEs  (Fig.  4C).  By  comparison,  NH  and  NAHR  based  mechanisms  occurred 
across  a  wide  size‐range,  whereas  VNTR  expansion/shrinkage,  consistent  with 
earlier findings1, led to relatively small SV sizes (Figs. 4C,D). 
Furthermore,  when  displaying  the  genomic  distribution  of  SVs  (Fig.  5A),  we 
observed a notable clustering of SVs into ‘SV hotspots’. We analyzed this clustering 





and  segmental  duplications  (P=3.1e‐17)  further  contributed  to  the  clustering 
(Supplementary Table 13).  










and  reference  genotypes,  we  demonstrate  the  suitability  of  population‐scale 
sequencing  for  SV  analysis.  Nucleotide  resolution  data  allow  the  construction  of 
reference datasets and make SVs readily assessable across different experimental 
platforms using genotyping approaches. Our fine‐scale map enabled us to examine 





are  hypothesized  to  be  associated  with  local  genome  architecture44,  e.g.,  with 
segmental  duplications  that  facilitate  NAHR.  Also,  DNA  rearrangement  in  the 
absence of homology, i.e., MMBIR, has been implicated in recurrent SV formation8,45. 
In this regard, we noticed that out of the hotspots we report, six fall into critical 
regions  of  known genetic  disorders  associated  with  recurrent de  novo deletions, 
including  Miller‐Dieker  syndrome  and  Leri‐Weill  dyschondrosteosis 
(Supplementary Table 14). Irrespective of potential disease relevance, or inferred 
mechanism  of  formation,  our  analysis  revealed  a  map  of  SV  hotspots  that  may 
constitute local centers of de novo SV formation, consistent with the concept that 
local genome architecture contributes to genomic instability44. 
Our  study  focused  on  characterizing  deletions,  which  are  often  associated  with 
disease9.  Facilitated  by  ancestral  analyses  of  SV  loci,  we  also  characterized 
insertions and tandem duplications, albeit in less detail than deletions.  Companion 
papers  with  more  detailed  analyses  of  MEIs,  and  copy‐number  variation  within 
segmental  duplications  are  published  elsewhere34,46.  Of  note,  most  SV  discovery 
methods  depend  on  mapping  reads  onto  their  genomic  locus  of  origin,  i.e.,  the 
‘accessible’ fraction of the genome, a fraction lessened in segmental duplications 
that are of high interest to SV analysis. Nonetheless, owing to the abilities of RP and 
RD  methods  in  detecting  SVs  in  these  regions  and  in  interpreting  reads  with 
multiple mapping positions, the ‘accessible’ fraction of the genome is higher for SVs 
than for SNPs16. In the future, sequencing technologies generating longer DNA reads 
will  increase  the  accessible  genome,  and  will  enable  the  assessment  of  SVs 
embedded in long repeat structures, such as balanced inversions. 
Our SV resource will enable the discovery, genotyping, and imputation of SVs in 
larger  cohorts.  Numerous  genomes  will  be  sequenced  in  the  coming  months  to 






Sequence  data  for  179  unrelated  individuals  and  six  individuals  from  parent‐
offspring trios were obtained as part of the 1000GP. These data were generated 










and  custom  microarray‐based  sequence  capture.  PCR  was  performed  in  various 



















Table 1. Summary of discovered structural variation 










Individual Callsets <10% FDR  11215  501  5371  -  17087 
Validated Experimentally
*  10810  -  -  128  10938 
         Release set  22025  501  5371  128  28025 




Table  2.  Functional  impact  of  our  fine  resolution  SV  set.  Figures  in  parentheses  indicate 
numbers of validated SVs per category. We inferred gene overlap with Gencode gene annotation
47. 
Gene Overlap 


















(631)                   
1093 
(1031)                         
315 
(290)              
7319 
(6481)                 
9381 





























































approach  evaluates  the  read  depth‐of‐coverage25,26;  the  SR  approach  maps  the 
boundaries  (breakpoints)  of  SVs  by  sequence  alignment28,29;  the  AS  approach 
assembles  SVs30,31,32.  B. Integrated  pipeline  for  SV  discovery,  validation,  and 
genotyping.  Colored  circles  represent  individual  SV  discovery  methods  (listed  in 
Supplementary  Table  1),  with  modes  indicated  by  a  color  scheme:  green=RP; 
yellow=RD; purple=SR; red=AS; green and yellow=methods evaluating RP and RD 
(abbreviated as ‘PD’). C. Example of a deletion, previously associated with BMI35,  














Tables  3,  4, 6 .  Vertical  dotted  lines  correspond  to  the  specificity  threshold 
(FDR≤10%). C. Breakpoint mapping resolution of three deletion discovery methods 
(the respective method names are in Supplementary Table 2). The blue and red 














or  “undetermined”  relative  to  inferred  ancestral  genomic  loci.  Gray  lines  mark 











relative  to  ancestral  loci.  Right  panel:  SVs  classified  as  insertions/duplications. 
C. Size  spectra  of  deletions  classified  relative  to  ancestral  loci.  D. Size  spectra  of 
insertions/duplications.  
Figure 5. Mapping hotspots of SV formation in the genome. A. Distribution of SVs 





events.  B. Enrichment  of  SVs  inferred  to  be  formed  by  the  same  formation 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